Invention Grant
- Patent Title: Compound, and production method thereof, and methods of treatment using the compound
-
Application No.: US16502663Application Date: 2019-07-03
-
Publication No.: US10975063B2Publication Date: 2021-04-13
- Inventor: Florence Mahuteau , Romain Najman , Jamal Tazi
- Applicant: ABIVAX , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT CURIE , UNIVERSITE DE MONTPELLIER
- Applicant Address: FR Paris; FR Paris; FR Paris; FR Montpellier
- Assignee: ABIVAX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT CURIE,UNIVERSITE DE MONTPELLIER
- Current Assignee: ABIVAX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT CURIE,UNIVERSITE DE MONTPELLIER
- Current Assignee Address: FR Paris; FR Paris; FR Paris; FR Montpellier
- Agency: Oliff PLC
- Priority: EP09162630 20090612,EP09305540 20090612
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; C07D213/74 ; C07D413/04 ; C07D215/38 ; C07D241/44 ; C07D401/12 ; C07D403/12 ; C07D217/02 ; A61K31/4985 ; C07D215/42 ; C07D215/46
Abstract:
The manufacture of 8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine, or a pharmaceutically acceptable salt thereof, and use of 8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine, or a pharmaceutically acceptable salt thereof, for treating various conditions, and/or inhibiting replication of HIV-1 in a patient infected with HIV-1, by administering to a patient in need thereof an effective quantity of 8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190322656A1 COMPOUND, AND PRODUCTION METHOD THEREOF, AND METHODS OF TREATMENT USING THE COMPOUND Public/Granted day:2019-10-24
Information query
IPC分类:
